{"transactions":[{"id":827631,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Restricted Stock Units","published_at":"2026-03-27T00:00:12.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":false,"shares":7515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."}],"balance_after":22547,"derivative":{"underlying":"Common Stock","underlying_shares":7515},"source":{"system":"sec-edgar","filing":"0001568249-26-000005","document":"form4-03262026_080308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000156824926000005/form4-03262026_080308.xml","form_type":"4"}},{"id":827630,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:12.000Z","date":"2026-03-25","kind":"sale","planned":false,"acquired":false,"shares":3844,"price":21.47,"value":82530.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":11280,"source":{"system":"sec-edgar","filing":"0001568249-26-000005","document":"form4-03262026_080308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000156824926000005/form4-03262026_080308.xml","form_type":"4"}},{"id":827629,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:12.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":true,"shares":7515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":15124,"source":{"system":"sec-edgar","filing":"0001568249-26-000005","document":"form4-03262026_080308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000156824926000005/form4-03262026_080308.xml","form_type":"4"}},{"id":851810,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T22:00:16.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":26382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 6, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 6, 2027."}],"balance_after":26382,"derivative":{"underlying":"Common Stock","underlying_shares":26382},"source":{"system":"sec-edgar","filing":"0001568249-26-000004","document":"form4-03102026_060312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000156824926000004/form4-03102026_060312.xml","form_type":"4"}},{"id":851809,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-10T22:00:16.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":90691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":90691,"derivative":{"exercise_price":22.16,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":90691},"source":{"system":"sec-edgar","filing":"0001568249-26-000004","document":"form4-03102026_060312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000156824926000004/form4-03102026_060312.xml","form_type":"4"}},{"id":912772,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Restricted Stock Units","published_at":"2026-02-10T23:00:04.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":12944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"50% of the restricted stock units vested on February 6, 2026 and 25% vest on each of February 6, 2027 and February 6, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"50% of the restricted stock units vested on February 6, 2026 and 25% vest on each of February 6, 2027 and February 6, 2028."}],"balance_after":12945,"derivative":{"underlying":"Common Stock","underlying_shares":12944},"source":{"system":"sec-edgar","filing":"0001568249-26-000002","document":"form4-02102026_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000156824926000002/form4-02102026_060201.xml","form_type":"4"}},{"id":912771,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Common Stock","published_at":"2026-02-10T23:00:04.000Z","date":"2026-02-09","kind":"sale","planned":false,"acquired":false,"shares":6950,"price":23.38,"value":162491.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.38 to $23.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7609,"source":{"system":"sec-edgar","filing":"0001568249-26-000002","document":"form4-02102026_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000156824926000002/form4-02102026_060201.xml","form_type":"4"}},{"id":912770,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Common Stock","published_at":"2026-02-10T23:00:04.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":12944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 595 shares of the Issuer's common stock acquired by the reporting person on May 15, 2025 pursuant to an employee stock purchase plan."}],"balance_after":14559,"source":{"system":"sec-edgar","filing":"0001568249-26-000002","document":"form4-02102026_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000156824926000002/form4-02102026_060201.xml","form_type":"4"}},{"id":1191455,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Restricted Stock Units","published_at":"2025-03-27T00:03:28.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":30062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."}],"balance_after":30062,"derivative":{"underlying":"Common Stock","underlying_shares":30062},"source":{"system":"sec-edgar","filing":"0001415889-25-009073","document":"form4-03272025_120324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009073/form4-03272025_120324.xml","form_type":"4"}},{"id":1191454,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-27T00:03:28.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":102289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 24, 2026. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":102289,"derivative":{"exercise_price":17.23,"expiration_date":"2035-03-23","underlying":"Common Stock","underlying_shares":102289},"source":{"system":"sec-edgar","filing":"0001415889-25-009073","document":"form4-03272025_120324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009073/form4-03272025_120324.xml","form_type":"4"}},{"id":1653942,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Restricted Stock Units","published_at":"2024-02-08T22:09:17.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":25889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the restricted stock units vest on February 6, 2026 and 25% vest on each of February 6, 2027 and February 6, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the restricted stock units vest on February 6, 2026 and 25% vest on each of February 6, 2027 and February 6, 2028."}],"balance_after":25889,"derivative":{"underlying":"Common Stock","underlying_shares":25889},"source":{"system":"sec-edgar","filing":"0001415889-24-003039","document":"form4-02082024_100202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924003039/form4-02082024_100202.xml","form_type":"4"}},{"id":1653941,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-08T22:09:17.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":126589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 6, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":126589,"derivative":{"exercise_price":25.74,"expiration_date":"2034-02-05","underlying":"Common Stock","underlying_shares":126589},"source":{"system":"sec-edgar","filing":"0001415889-24-003039","document":"form4-02082024_100202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924003039/form4-02082024_100202.xml","form_type":"4"}},{"id":2349656,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T16:21:14.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022."}],"balance_after":275000,"derivative":{"exercise_price":1.99,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001601485-22-000012","document":"wf-form4_164642885246988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148522000012/wf-form4_164642885246988.xml","form_type":"4"}},{"id":2349655,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T16:21:14.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the \"Vesting Commencement Date\"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":175000,"derivative":{"exercise_price":1.99,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001601485-22-000012","document":"wf-form4_164642885246988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148522000012/wf-form4_164642885246988.xml","form_type":"4"}},{"id":2471232,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-15T16:06:37.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":451,"price":2.4171,"value":1090.1121,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted by the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.41 to $2.42 inclusive."}],"balance_after":30399,"source":{"system":"sec-edgar","filing":"0001601485-21-000083","document":"wf-form4_163960237655604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148521000083/wf-form4_163960237655604.xml","form_type":"4"}},{"id":2509954,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-16T16:09:01.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":433,"price":4.4,"value":1905.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted by the Issuer."}],"balance_after":30850,"source":{"system":"sec-edgar","filing":"0001601485-21-000072","document":"wf-form4_163709656126099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148521000072/wf-form4_163709656126099.xml","form_type":"4"}},{"id":2541371,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-15T16:10:01.000Z","date":"2021-10-14","kind":"sale","acquired":false,"shares":430,"price":8.65,"value":3719.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted by the Issuer."}],"balance_after":31283,"source":{"system":"sec-edgar","filing":"0001601485-21-000060","document":"wf-form4_163432858580303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148521000060/wf-form4_163432858580303.xml","form_type":"4"}},{"id":2568709,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-15T16:31:03.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":430,"price":10.64,"value":4575.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted by the Issuer."}],"balance_after":31713,"source":{"system":"sec-edgar","filing":"0001601485-21-000056","document":"wf-form4_163173783565355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148521000056/wf-form4_163173783565355.xml","form_type":"4"}},{"id":2599313,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-17T16:05:49.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":445,"price":10.68,"value":4752.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted by the Issuer."}],"balance_after":32143,"source":{"system":"sec-edgar","filing":"0001601485-21-000050","document":"wf-form4_162923072024903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148521000050/wf-form4_162923072024903.xml","form_type":"4"}},{"id":2626949,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-07-22T18:06:28.000Z","date":"2021-07-21","kind":"sale","acquired":false,"shares":432,"price":10.94,"value":4726.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted by the Issuer."}],"balance_after":32588,"source":{"system":"sec-edgar","filing":"0001601485-21-000040","document":"wf-form4_162699156354918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148521000040/wf-form4_162699156354918.xml","form_type":"4"}},{"id":2632998,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-07-15T16:08:19.000Z","date":"2021-07-14","kind":"sale","acquired":false,"shares":431,"price":11.01,"value":4745.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted by the Issuer."}],"balance_after":32589,"source":{"system":"sec-edgar","filing":"0001601485-21-000033","document":"wf-form4_162637966140096.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148521000033/wf-form4_162637966140096.xml","form_type":"4"}},{"id":2665610,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-06-16T16:06:24.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":427,"price":13.27,"value":5666.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted by the Issuer."}],"balance_after":33020,"source":{"system":"sec-edgar","filing":"0001601485-21-000027","document":"wf-form4_162387395891013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148521000027/wf-form4_162387395891013.xml","form_type":"4"}},{"id":2707237,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-18T16:04:40.000Z","date":"2021-05-14","kind":"sale","acquired":false,"shares":440,"price":13.92,"value":6124.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") granted by the Issuer."}],"balance_after":33447,"source":{"system":"sec-edgar","filing":"0001601485-21-000023","document":"wf-form4_162136823397793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148521000023/wf-form4_162136823397793.xml","form_type":"4"}},{"id":2748301,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-15T16:05:51.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":399,"price":15.01,"value":5988.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were effected pursuant to a 10b-5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a Restricted Stock Units (\"RSUs\") of the Issuer."}],"balance_after":33887,"source":{"system":"sec-edgar","filing":"0001601485-21-000011","document":"wf-form4_161851712866164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000160148521000011/wf-form4_161851712866164.xml","form_type":"4"}},{"id":2785463,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-16T16:11:06.000Z","date":"2021-03-13","kind":"sale","acquired":false,"shares":499,"price":20.45,"value":10204.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to the Issuer solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a Restricted Stock Units (\"RSUs\") of the Issuer."}],"balance_after":34286,"source":{"system":"sec-edgar","filing":"0001567619-21-006400","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000156761921006400/doc1.xml","form_type":"4"}},{"id":2853352,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-17T20:10:35.000Z","date":"2021-02-13","kind":"sale","acquired":false,"shares":457,"price":19.54,"value":8929.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a Restricted Stock Units (\"RSUs\") of the Issuer."}],"balance_after":34785,"source":{"system":"sec-edgar","filing":"0001567619-21-004331","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000156761921004331/doc1.xml","form_type":"4"}},{"id":2874058,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-08T12:56:56.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":70012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 4, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":70012,"derivative":{"exercise_price":16,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":70012},"source":{"system":"sec-edgar","filing":"0001567619-21-002410","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568249/000156761921002410/doc1.xml","form_type":"4"}},{"id":3481023,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Common Stock","published_at":"2019-06-21T17:38:30.000Z","date":"2019-06-20","kind":"sale","acquired":false,"shares":940,"price":5.35,"value":5029.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,442 shares purchased on 5/31/19 through the issuer's employee stock purchase plan."}],"balance_after":63114,"source":{"system":"sec-edgar","filing":"0001209191-19-038602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919119038602/doc4.xml","form_type":"4"}},{"id":3558295,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-10T16:33:14.000Z","date":"2019-04-08","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with May 1, 2019, subject to Reporting Person's Continuous Service as of each such date."}],"balance_after":60000,"derivative":{"exercise_price":6.81,"expiration_date":"2029-04-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-19-024244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919119024244/doc4.xml","form_type":"4"}},{"id":3558294,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Common Stock","published_at":"2019-04-10T16:33:14.000Z","date":"2019-04-08","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2020, March 20, 2021, March 20, 2022 and March 20, 2023, subject to Reporting Person's Continuous Service as of each such date."}],"balance_after":61612,"source":{"system":"sec-edgar","filing":"0001209191-19-024244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919119024244/doc4.xml","form_type":"4"}},{"id":3582737,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Common Stock","published_at":"2019-03-21T16:39:53.000Z","date":"2019-03-20","kind":"sale","acquired":false,"shares":1792,"price":7.99,"value":14318.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $7.94 to $8.03.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31612,"source":{"system":"sec-edgar","filing":"0001209191-19-020769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919119020769/doc4.xml","form_type":"4"}},{"id":3720793,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Common Stock","published_at":"2018-12-21T16:47:28.000Z","date":"2018-12-20","kind":"sale","acquired":false,"shares":425,"price":7.52,"value":3196.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $7.50 to $7.52.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 35 shares purchased on 11/30/18 through the issuer's employee stock purchase plan."}],"balance_after":33404,"source":{"system":"sec-edgar","filing":"0001209191-18-063937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919118063937/doc4.xml","form_type":"4"}},{"id":3884763,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Common Stock","published_at":"2018-06-22T16:50:14.000Z","date":"2018-06-21","kind":"sale","acquired":false,"shares":1002,"price":25.48,"value":25530.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $25.45 to $25.50.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 668 shares purchased on 5/31/18 through the issuer's employee stock purchase plan."}],"balance_after":33794,"source":{"system":"sec-edgar","filing":"0001209191-18-039257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919118039257/doc4.xml","form_type":"4"}},{"id":3984822,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Common Stock","published_at":"2018-03-22T17:56:18.000Z","date":"2018-03-21","kind":"sale","acquired":false,"shares":982,"price":25.89,"value":25423.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $25.81 to $25.95.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":34128,"source":{"system":"sec-edgar","filing":"0001209191-18-021317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919118021317/doc4.xml","form_type":"4"}},{"id":4002865,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-09T20:53:29.000Z","date":"2018-03-06","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with April 1, 2018, subject to Reporting Person's Continuous Service as of each such date."}],"balance_after":37500,"derivative":{"exercise_price":25.66,"expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-18-018676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919118018676/doc4.xml","form_type":"4"}},{"id":4002864,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Common Stock","published_at":"2018-03-09T20:53:29.000Z","date":"2018-03-06","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2019, March 20, 2020, March 20, 2021 and March 20, 2022, subject to Reporting Person's Continuous Service as of each such date."}],"balance_after":35110,"source":{"system":"sec-edgar","filing":"0001209191-18-018676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919118018676/doc4.xml","form_type":"4"}},{"id":4123446,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Common Stock","published_at":"2017-12-21T16:43:15.000Z","date":"2017-12-21","kind":"sale","acquired":false,"shares":440,"price":32.3,"value":14212.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 845 shares purchased on 11/30/17 through the issuer's employee stock purchase plan."}],"balance_after":28860,"source":{"system":"sec-edgar","filing":"0001209191-17-066810","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919117066810/doc4.xml","form_type":"4"}},{"id":4274342,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Common Stock","published_at":"2017-06-22T17:05:11.000Z","date":"2017-06-21","kind":"sale","acquired":false,"shares":1041,"price":17.5348,"value":18253.7268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $17.531 to $17.535.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,259 shares purchased on 5/31/17 through the issuer's employee stock purchase plan."}],"balance_after":28455,"source":{"system":"sec-edgar","filing":"0001209191-17-041439","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919117041439/doc4.xml","form_type":"4"}},{"id":4485080,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-20T18:15:46.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall become vested according to the following schedule: 1/48th of the shares subject to the option shall vest monthly beginning on February 1, 2017 for 48 months."}],"balance_after":67500,"derivative":{"exercise_price":16.61,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001209191-17-004978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919117004978/doc4.xml","form_type":"4"}},{"id":4485079,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, GC & Compliance Officer"}}],"security":"Common Stock","published_at":"2017-01-20T18:15:46.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest 1/4th on each of March 20, 2018, March 20, 2019, March 20, 2020 and March 20, 2021."}],"balance_after":27187,"source":{"system":"sec-edgar","filing":"0001209191-17-004978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919117004978/doc4.xml","form_type":"4"}},{"id":4563591,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-08T16:33:38.000Z","date":"2016-11-07","kind":"grant","acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option shall vest on October 29, 2017, and the remaining shares will vest in equal monthly installments over the next 36 months."}],"balance_after":28125,"derivative":{"exercise_price":14.26,"expiration_date":"2026-11-06","underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001209191-16-148867","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919116148867/doc4.xml","form_type":"4"}},{"id":4563590,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":55898,"kind":"person","name":"Rhodes Jennifer J","position":1,"cik":"0001568249","reported_name":"Rhodes Jennifer J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2016-11-08T16:33:38.000Z","date":"2016-11-07","kind":"grant","acquired":true,"shares":4687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest 1/4th on each of December 20, 2017, December 20, 2018, December 20, 2019, and December 20, 2020."}],"balance_after":15937,"source":{"system":"sec-edgar","filing":"0001209191-16-148867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919116148867/doc4.xml","form_type":"4"}}]}